Pluristem Completed Successful Meeting With FDA in Preparation for Filing an IND for PLX-R18
September 09, 2015 at 04:18 AM EDT
Pluristem Therapeutics Inc. (Nasdaq: PSTI) today announced that it has completed a successful meeting with the U.S. Food and Drug ...
